ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
3
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,865
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Biologics inch toward cholesterol-lowering market.
Author(s):
Ken Garber
Publication date:
2012-03-31
Journal:
Nature biotechnology
Keywords:
Clinical Trials, Phase III as Topic
,
economics
,
Drug Approval
,
Drug Industry
,
Humans
,
Hypercholesterolemia
,
therapy
,
Lipoproteins, LDL
,
Proprotein Convertases
,
therapeutic use
,
Serine Endopeptidases
,
United States
,
United States Food and Drug Administration
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
The Journal of Prediction Markets
Author and article information
Journal
PubMed ID::
22491269
DOI::
10.1038/nbt0412-302
ScienceOpen disciplines:
Chemistry
Keywords:
Clinical Trials, Phase III as Topic
,
economics
,
Drug Approval
,
Drug Industry
,
Humans
,
Hypercholesterolemia
,
therapy
,
Lipoproteins, LDL
,
Proprotein Convertases
,
therapeutic use
,
Serine Endopeptidases
,
United States
,
United States Food and Drug Administration
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Clinical Trials, Phase III as Topic
,
economics
,
Drug Approval
,
Drug Industry
,
Humans
,
Hypercholesterolemia
,
therapy
,
Lipoproteins, LDL
,
Proprotein Convertases
,
therapeutic use
,
Serine Endopeptidases
,
United States
,
United States Food and Drug Administration
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,865
Photopeak Counting Efficiencies for 3 X 3 Inch Solid and Well-Type Nal Scintillation Crystals
Authors:
Ray Gunnink
,
A. W. Stoner
Pulkovo catalog of relative positions and motions of visual double and multiple stars from photographic observations with the 26-inch refractor in 1960-2007
Authors:
A. Kiselev
,
O. Kiyaeva
,
I V Izmailov
…
Four inches by three inches plastic scintillator for routine Co60 vitamin B12 uptakes
Authors:
See all similar
Cited by
3
Proof of concept for next-generation nanoparticle drugs in humans.
Authors:
Cormac Sheridan
New class PCSK9 blockers stride into cholesterol market
Authors:
Cormac Sheridan
PCSK9 Antibodies for the Treatment of Hypercholesterolemia
Authors:
Ioanna Gouni-Berthold
,
Heiner K. Berthold
See all cited by